Core Viewpoint - The report from Credit Lyonnais indicates that Fosun Pharma's Q2 performance shows resilience, with a quarterly revenue increase of 7.2% and a net profit increase of 22.5%, primarily driven by strong sales of innovative products [1] Group 1 - The new Employee Stock Ownership Plan (ESOP) is expected to provide greater visibility for growth and alleviate market concerns following leadership changes [1] - The company successfully completed two licensing agreements for independently developed molecules [1] Group 2 - Credit Lyonnais has raised its core profit forecast for Fosun Pharma for the years 2023 to 2027 by approximately 13% to 21% [1] - The target price for Fosun Pharma's H-shares has been increased from HKD 15.6 to HKD 29.6, while maintaining an "outperform" rating [1]

Core Points - The company has established a 2025 Employee Stock Ownership Plan (ESOP) to enhance the alignment of interests between employees and shareholders, improve corporate governance, and boost employee motivation and creativity for sustainable development [1][2] - The ESOP will be implemented in compliance with relevant laws and regulations, ensuring voluntary participation and risk-bearing by employees [2][3] - The total number of employees participating in the ESOP will not exceed 111, with a proposed share allocation of 640,000 shares for directors and senior management, representing 22.22% of the total shares [3][4] Summary by Sections Chapter 1: General Provisions - The ESOP is designed to comply with the Company Law, Securities Law, and other relevant regulations [1] Chapter 2: Formulation of the Employee Stock Ownership Plan - The purpose of the ESOP is to create a profit-sharing mechanism and enhance company competitiveness [2] - The plan adheres to principles of legality, voluntary participation, and risk-bearing by employees [2] Chapter 3: Funding Sources, Stock Sources, Purchase Price, and Scale - The total funds raised for the ESOP will not exceed RMB 27.216 million, with a maximum of 2.88 million shares available for purchase at a price of RMB 9.45 per share [6][8] - The shares will be sourced from the company's repurchased A-shares [7][8] Chapter 4: Duration, Lock-up Period, and Unlocking Arrangements - The ESOP will last for 80 months, with specific unlocking arrangements for shares based on performance metrics [10][11] Chapter 5: Participation in Company Financing - The management committee will decide on participation in financing activities during the ESOP's duration [13] Chapter 6: Management of the Employee Stock Ownership Plan - The ESOP will be managed by a management committee responsible for daily operations and safeguarding participants' rights [14][15] Chapter 7: Changes, Termination, and Rights Disposal - The ESOP can be modified or terminated based on the approval of the majority of participants [20][21] Chapter 8: Supplementary Provisions - The ESOP does not guarantee continued employment for participants, and tax liabilities will be borne by the employees [28][29]

Group 1 - The board of directors of Yuanli Chemical Group Co., Ltd. held its seventh meeting on August 27, 2025, with all nine directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the proposal for the 2025 semi-annual report and its summary, with a unanimous vote of 9 in favor [1] - The board also approved the proposal to cancel the supervisory board and amend the company’s articles of association, which will be submitted for review at the first extraordinary general meeting of shareholders in 2025 [2] Group 2 - The board approved the proposal for the 2025 employee stock ownership plan (draft) and its summary, with 6 votes in favor and 3 abstentions from related directors [3] - The board approved the proposal for the management measures of the 2025 employee stock ownership plan, with the same voting results as the previous proposal [3] - The board proposed to authorize the board to handle matters related to the 2025 employee stock ownership plan, which will also be submitted for review at the first extraordinary general meeting of shareholders in 2025 [4] Group 3 - The board proposed to convene the first extraordinary general meeting of shareholders in 2025, with a unanimous vote of 9 in favor [4]

Core Viewpoint - The company is set to implement a 2025 employee stock ownership plan aimed at enhancing employee motivation, cohesion, and overall competitiveness while promoting sustainable development and governance improvement [1] Summary by Relevant Sections - **Employee Stock Ownership Plan** The 2025 employee stock ownership plan is designed to establish a long-term and effective incentive mechanism, which will help in mobilizing employee enthusiasm and improving the company's competitiveness [1] - **Compliance and Governance** The plan adheres to relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China, and does not harm the interests of the company or its shareholders [1] - **Participation Principles** The plan follows principles of legality, voluntary participation, and risk-bearing by employees, ensuring there is no forced participation or distribution [1]

表决结果：3 票同意，0 票反对，0 票弃权。 元利化学集团股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 元利化学集团股份有限公司（以下简称"公司"）第五届监事会第六次会议 于 2025 年 8 月 27 日以现场及通讯表决方式召开。会议通知于 2025 年 8 月 22 日以电话及电子邮件方式通知全体监事。会议应参加监事 3 人，实际参加表决监 事 3 人。会议由监事会主席黄维君先生召集并主持，董事会秘书列席了本次会议。 会议的召开符合《公司法》及《公司章程》的规定，形成的决议事项合法、有效。 二、监事会会议审议情况 （一）审议通过了《关于公司<2025 年半年度报告>及摘要的议案》 监事会认为：公司《2025 年半年度报告》及其摘要的编制和审议程序符合 法律法规、中国证监会及上海证券交易所有关规定的要求，报告内容能够真实、 准确、完整地反映出公司报告期经营管理和财务状况，不存在任何虚假记载、误 导性陈述或者重大遗漏。在提出本意见前，未发现参与报告编制和审议的人员有 违反信息披露 ...

制，健全公司长期、有效的激励约束机制，充分调动员工积极性，提高员工的凝 聚力和公司竞争力；同时，有助于公司进一步完善治理水平，促进公司健康长远 可持续发展。 员工持股计划试点的指导意见》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等相关文件的规定，不存在损害公司和全体股东利益的情形。 象遵循依法合规、自愿参与、风险自担的原则，不存在摊派、强行分配等方式强 制员工参与员工持股计划的情形。 元利化学集团股份有限公司 监事会关于公司 2025 年员工持股计划相关事项的核 查意见 元利化学集团股份有限公司（以下简称"公司"）监事会依据《中华人民共 和国公司法》《中华人民共和国证券法》《关于上市公司实施员工持股计划试点 的指导意见》等有关法律、法规以及《元利化学集团股份有限公司章程》的规定， 对公司 2025 年员工持股计划（以下简称"本次员工持股计划"）相关事项发表 如下意见： 综上所述，我们同意公司实施本次员工持股计划。 元利化学集团股份有限公司 监事会 ...

Meeting Information - The shareholders' meeting of Yuanli Chemical Group Co., Ltd. is scheduled for September 16, 2025, at 14:30 [1] - The meeting will be held at the company's conference room in Changle County, Weifang City [1] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's network voting system [1] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange network voting system from 9:15 to 15:00 on the day of the meeting [1][2] - Specific voting times through the trading system are from 9:15-9:25, 9:30-11:30, and 13:00-15:00 [1] - Shareholders holding multiple accounts can aggregate their voting rights across all accounts [3] Agenda Items - The meeting will review several proposals related to the 2025 Employee Stock Ownership Plan, including the draft plan and its management measures [2][8] - Shareholders with a conflict of interest regarding the employee stock ownership plan are required to abstain from voting [2] Attendance Requirements - Only shareholders registered by the close of trading on September 9, 2025, are eligible to attend the meeting [3] - Shareholders can appoint proxies to attend and vote on their behalf [3] Registration Process - Corporate shareholders must provide specific documentation for registration, including a business license and identification [4] - Individual shareholders must present their stock account card and identification for registration [4]

Core Viewpoint - The company is proposing an employee stock ownership plan (ESOP) for 2025, which requires approval from the shareholders' meeting to be implemented. The plan's success is uncertain due to various factors, including employee participation and funding sources [1][2]. Group 1: Plan Overview - The ESOP is designed in accordance with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [2]. - The plan is voluntary, with a maximum of 111 employees participating, including key management and core personnel [2][9]. - The total funding to be raised through the plan is capped at 27.216 million yuan, with each share priced at 9.45 yuan [3][13]. Group 2: Funding and Share Allocation - The funding sources for the ESOP include employees' own funds and legally permitted methods, with no financial assistance provided by the company [3][12]. - The total number of shares held by the ESOP will not exceed 10% of the company's total equity, and individual employee holdings will not exceed 1% [4][9]. - The plan includes a reserve of 382,000 shares, accounting for 13.26% of the total shares, to attract and retain talent [3][11]. Group 3: Lock-up and Vesting Period - The ESOP has a duration of 80 months, with shares vesting in three phases: 30% after 12 months, 30% after 24 months, and 40% after 36 months [5][18]. - The plan allows for early termination or extension under certain conditions, subject to approval from the holders' meeting [17][23]. Group 4: Performance Assessment - The plan includes performance targets for both company and individual levels, with specific revenue growth rates set for the years 2025 to 2027 [19][20]. - If performance targets are not met, unvested shares may be repurchased by the company at the original investment amount plus interest [20][21]. Group 5: Management and Governance - The ESOP will be managed by a committee representing the participants, ensuring the protection of their rights and interests [22]. - Any changes to the plan must be approved by a two-thirds majority of the holders' meeting [23].

公司《2025年员工持股计划（草案）》及其摘要符合《中华人民共和国公司 法》《中华人民共和国证券法》《关于上市公司实施员工持股计划试点的指导意 见》《上海证券交易所上市公司自律监管指引第1号——规范运作》等有关法律 法规和规范性文件以及《公司章程》的规定，遵循依法合规、自愿参与、风险自 担的基本原则，在实施本次员工持股计划前充分征求了公司员工意见。公司实施 本次员工持股计划有利于建立和完善公司、股东和员工的利益共享机制，提升员 工的凝聚力和公司竞争力，充分调动员工的积极性和创造性，实现公司长期、可 持续发展。本次员工持股计划不存在损害公司及全体股东利益的情形，亦不存在 摊派、强行分配等方式强制员工参加的情形。 经与会职工代表充分讨论，一致同意公司《2025 年员工持股计划（草案）》 及其摘要的内容。 特此公告。 证券代码：603217 证券简称：元利科技 公告编号：2025-024 元利化学集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 元利化学集团股份有限公司（以下简称"公司"） 于 2025 年 8 ...

证券代码：002298 证券简称：中电鑫龙 编号：2025-050 安徽中电鑫龙科技股份有限公司 第十届董事会第三次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 一、董事会会议召开情况 安徽中电鑫龙科技股份有限公司（以下简称"公司"或"本公司"）第十届董 事会第三次会议于 2025 年 8 月 15 日以专人送达、电子邮件、通讯方式向全体董事 发出召开第十届董事会第三次会议的通知。会议于 2025 年 8 月 27 日以现场和通讯 相结合的方式召开。会议应出席董事 9 人，实际出席董事 9 人。会议符合《公司法》 和《公司章程》的有关规定。本次会议由公司董事长瞿洪桂先生主持。 二、董事会会议审议情况 经与会董事表决，通过如下决议： （一）会议以 9 票同意、0 票反对、0 票弃权的表决结果，审议通过了《2025 年半年度报告及摘要的议案》。 具体详见《2025 年半年度报告全文》、《2025 年半年度报告摘要》。 （二）会议以 5 票同意、0 票反对、0 票弃权的表决结果，审议通过了《关于变 更公司员工持股计划部分条款的议案》。 根据《上市公司实施 ...